Joan B. Soriano Ortíz-rekin lankidetzan egindako argitalpenak (25)

2020

  1. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  2. Sex differences between women and men with COPD: A new analysis of the 3CIA study

    Respiratory Medicine, Vol. 171

2019

  1. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  2. New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD

    European Respiratory Journal, Vol. 53, Núm. 6

2018

  1. A multicentre, randomized controlled trial of telehealth for the management of COPD

    Respiratory Medicine, Vol. 144, pp. 74-81

  2. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  3. Efficacy and costs of telehealth for the management of COPD: The PROMETE II trial

    European Respiratory Journal

  4. Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease

    BMC Medicine, Vol. 16, Núm. 1

  5. Temporal transitions in COPD severity stages within the GOLD 2017 classification system

    Respiratory Medicine, Vol. 142, pp. 81-85

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

  2. Multiple Score Comparison: A network meta-analysis approach to comparison and external validation of prognostic scores

    BMC Medical Research Methodology, Vol. 17, Núm. 1

  3. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

  4. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2016

  1. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52

  2. Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort

    PLoS ONE, Vol. 11, Núm. 9

  3. Prognostic assessment in COPD without lung function: The B-AE-D indices

    European Respiratory Journal, Vol. 47, Núm. 6, pp. 1635-1644

2015

  1. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168

  2. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data

    The Lancet Respiratory Medicine, Vol. 3, Núm. 6, pp. 443-450

2014

  1. Clinical application of the COPD assessment test: Longitudinal data from the COPD history assessment in Spain (CHAIN) Cohort

    Chest, Vol. 146, Núm. 1, pp. 111-122

  2. Erratum: New GOLD classification: Longitudinal data on group assignment [Respir Res. 15, (2014) 3, 10.1186/1465-9921-15-3]

    Respiratory Research